Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Algorithm Guided Treatment vs TAU in MDD
NCT01764867Phase 4Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- Jun 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram, mirtazapine in major depressive disorder (MDD), sponsored by Shanghai Mental Health Center. Status: unknown.
02
Drugs
escitaloprammirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01764867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01764867.